Amundi
USNA icon

Amundi’s Usana Health Sciences USNA Stock Holding History

Amundi’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,986
Closed -$102K – 2157
2025
Q1 		$102K Sell
3,986
-886
-18% -$28.1K ﹤0.01% 1746
2024
Q4 		$170K Buy
4,872
+2,243
+85% +$83.9K ﹤0.01% 1737
2024
Q3 		$94.8K Buy
2,629
+393
+18% +$16.1K ﹤0.01% 1781
2024
Q2 		$101K Buy
+2,236
New +$103K ﹤0.01% 1706
2023
Q2 		– Sell
-1,516
Closed -$97K – 2133
2023
Q1 		$97K Sell
1,516
-7,074
-82% -$422K ﹤0.01% 1744
2022
Q4 		$494K Buy
+8,590
New +$465K ﹤0.01% 1402
2022
Q3 		– Sell
-11,534
Closed -$751K – 1899
2022
Q2 		$751K Hold
11,534
– – ﹤0.01% 1215
2022
Q1 		$914K Hold
11,534
– – ﹤0.01% 1228
2021
Q4 		$1.17M Hold
11,534
– – ﹤0.01% 1273
2021
Q3 		$1.06M Hold
11,534
– – ﹤0.01% 1280
2021
Q2 		$1.18M Buy
+11,534
New +$1.16M ﹤0.01% 1206

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Amundi's USNA Position: Q2 2025 in Review

Amundi sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 3,986 shares — an estimated $102K sold.

Amundi first reported a position in USNA in Q2 2021 and held it in 11 quarters. The position peaked at $1.18M in Q2 2021. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

  • Amundi reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 3,986 Usana Health Sciences shares in Q2 2025, an estimated $102K.
  • Amundi first reported a position in Usana Health Sciences in Q2 2021 and held it in 11 quarters.
  • Amundi's Usana Health Sciences position peaked at $1.18M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.